Boston, Massachusetts, USA – February 19, 2025 – ArisGlobal, a technology company at the forefront of life sciences, has announced a strategic partnership with Celegence, a global provider of regulatory affairs services and innovative solutions for the life sciences industry. This unique collaboration combines ArisGlobal’s extensive life sciences experience and technological innovation with Celegence’s regulatory operations expertise, offering customers seamless adoption and implementation of LifeSphere® solutions, enhancing efficiency and compliance.
The partnership is designed to transform regulatory teams’ operations by unifying actionable data streams, fostering robust governance, and providing visibility across regulatory operations. With a global presence, the collaboration offers comprehensive support for data governance, IDMP compliance, and operational excellence across the pharmaceutical, medical device, and cosmetics sectors. Customers will benefit from tailored solutions that simplify regulatory workflows, reduce complexity, and enable sustained success in an evolving industry landscape.
Raj Hattarki, Chief Operating Officer at ArisGlobal, said, “Our partnership with Celegence underscores our steadfast commitment to delivering high-impact, customer-centric solutions that revolutionize regulatory business processes and accelerate success for life sciences organizations. By leveraging cutting-edge automation technologies, this collaboration introduces an integrated approach that streamlines regulatory workflows, enhances compliance, and drives operational efficiency. Together, we empower life sciences companies to navigate complex regulatory landscapes confidently, enabling them to adopt transformative, technology-driven solutions that optimize productivity while ensuring adherence to global compliance standards. This strategic alliance brings together ArisGlobal’s deep expertise in Regulatory Information Management (RIM) technology with Celegence’s proficiency in regulatory business process services, offering a seamless, end-to-end solution designed to accelerate regulatory submissions, reduce operational burdens, and drive digital transformation in regulatory affairs. Through this partnership, we reaffirm our shared vision of equipping life sciences organizations with innovative, scalable, and future-ready solutions that maximize agility, ensure compliance, and enhance overall regulatory excellence.”
Lakshmeenarayana Goundalkar, Chief Delivery Officer at Celegence, added, “We are thrilled to partner with ArisGlobal. This collaboration reflects our shared commitment to empowering life sciences companies with innovative tools and services that enhance productivity, improve business processes, and ensure compliance. We look forward to supporting organizations in navigating the evolving regulatory environment, achieving their goals with unparalleled efficiency, and accelerating the delivery of life-saving therapies to the market.”
This partnership further solidifies ArisGlobal’s position as a leader in the regulatory space, reinforcing its commitment to driving innovation and delivering tangible impact for customers worldwide.
About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming how today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.
About Celegence
Celegence, creator of the CAPTIS® AI platform, provides a comprehensive range of tech-empowered regulatory affairs services for pharmaceutical, medical device, and IVD manufacturers seeking to balance the quality, timelines, and cost of their regulatory compliance. Headquartered in the United States, Celegence has offices in Europe and India. For more updates, follow Celegence on LinkedIn.
